Allergic Immunologic

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC1-3

DiraChart Clinical Reference
Protected section 3 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 25PreviousNext

2. What the clinician must assess

A complete allergic and immunologic assessment addresses each of the following as indicated by the patient’s condition and orders, and compares each finding to baseline.

  • Allergy history — the reconciled list of allergies and the nature and severity of prior reactions.
  • Current reaction signs — urticaria, angioedema, wheeze or stridor, gastrointestinal symptoms, and hypotension suggesting an allergic reaction or anaphylaxis.
  • Anaphylaxis readiness — the availability and expiration of the epinephrine auto-injector, the patient’s and caregiver’s technique, and the action plan.
  • Immune status — immunosuppressant therapy, transplant status, or a condition causing immunocompromise, and the resulting infection risk (neutropenia is documented with Hematologic).
  • Infection surveillance — fever and infection signs, treated as urgent in immunosuppression.
  • Immunosuppressant monitoring — the regimen, adherence, and signs of toxicity or adverse effects.
  • Vaccine status — currency of recommended vaccinations within the patient’s plan.
  • Allergen exposures — known triggers in the home and the avoidance plan.
  • Vital signs and airway status where a reaction is present.
  • The patient’s adherence to the action plan, avoidance measures, and infection precautions.
Section NavigationPart 3 of 25PreviousNext